Get the Stockscreener App
10.39
1.05%
-0.11
After Hours:
10.25
-0.14
-1.35%
Adaptive Biotechnologies Corp Stock (ADPT) Forecast
The Adaptive Biotechnologies Corp (ADPT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $4.4406, representing a -57.26% decrease from the current price of $10.39. The highest analyst price target is $8.65, and the lowest is $0.2312.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ADPT Price Target
Average 19.74
(+90.02% Upside)
Is Adaptive Biotechnologies Corp (ADPT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 41.41 | Neutral |
| STOCH(9,6) | 18.96 | Buy |
| STOCHRSI(14) | 15.71 | Buy |
| MACD(12,26) | 0.1639 | Sell |
| ADX(14) | 33.83 | Sell |
| William %R | -93.35 | Buy |
| CCI(14) | -112.02 | Sell |
Buy: 3
Sell: 3
Neutral: 1
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
11.36
Sell
|
11.10
Sell
|
| MA20 |
11.36
Sell
|
11.09
Sell
|
| MA50 |
10.31
Buy
|
10.38
Buy
|
| MA100 |
9.073
Buy
|
9.3791
Buy
|
| MA200 |
7.652
Buy
|
7.9326
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, ADPT could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 7 signaling Sell signals and 1 Neutral signals. This might be a good time to open fresh positions on ADPT, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 41.41 indicates that ADPT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 18.96 indicates that ADPT is oversold. This indicates that ADPT price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 15.71 indicates that ADPT is oversold. This suggests that ADPT price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 33.83 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -112.02 indicates that ADPT is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term ADPT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Adaptive Biotechnologies Corp financial reports and earnings history, Adaptive Biotechnologies Corp (ADPT) stock could reach $42.64 by 2030, $21.05 by 2040 and $77.43 by 2050. See the projected annual prices until 2050 of the Adaptive Biotechnologies Corp stock below:
- Adaptive Biotechnologies Corp (ADPT) is expected to reach an average price of $5.5912 in 2035, with a high prediction of $6.2539 and a low estimate of $5.9062. This indicates an $-46.19% rise from the last recorded price of $10.39.
- Adaptive Biotechnologies Corp (ADPT) stock is projected to chart a bullish course in 2040, with an average price target of $19.45, representing an $87.24% surge from its current level. The forecast ranges from a conservative $19.54 to a sky-high $21.05.
- Our analysts predict Adaptive Biotechnologies Corp (ADPT) to jump 305.46% by 2045, soaring from $42.89 to an average price of $42.13, potentially reaching $43.18. While $42.89 is the low estimate, the potential upside is significant.
- Adaptive Biotechnologies Corp (ADPT) stock is expected to climb by 2050, reaching an average of $76.15, a $632.92% jump from its current level. However, a wide range of estimates exists, with high and low targets of $77.43 and $76.57, respectively, highlighting the market's uncertainty.
Adaptive Biotechnologies Corp Stock (ADPT) Year by Year Forecast
Adaptive Biotechnologies Corp Stock (ADPT) Price Forecast for 2025
Adaptive Biotechnologies Corp Stock (ADPT) is expected to reach an average price of $12.34 in 2025, with a high prediction of $24.67 and a low estimate of $0.00118. This indicates an +18.72% rise from the last recorded price of $10.39.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| August, 2025 | $5.46 | $0.2312 | $8.65 | -47.45% |
| September, 2025 | $11.60 | $0.00118 | $13.61 | +11.62% |
| October, 2025 | $17.68 | $9.9271 | $20.19 | +70.21% |
| November, 2025 | $16.31 | $11.31 | $20.42 | +57.00% |
| December, 2025 | $23.39 | $11.04 | $24.67 | +125.11% |
Adaptive Biotechnologies Corp Stock (ADPT) Price Forecast for 2026
The predicted value for Adaptive Biotechnologies Corp (ADPT) in 2026 is set at an average of $20.34. Estimates vary from a peak of $39.49 to a trough of $1.1859, indicating an +95.73% surge from the present price of $10.39.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $28.22 | $22.24 | $33.33 | +171.58% |
| February, 2026 | $29.89 | $22.69 | $39.49 | +187.73% |
| March, 2026 | $11.36 | $7.3823 | $36.02 | +9.36% |
| April, 2026 | $10.65 | $5.27 | $16.55 | +2.50% |
| May, 2026 | $12.08 | $9.3282 | $15.45 | +16.24% |
| June, 2026 | $8.8847 | $1.1859 | $12.61 | -14.49% |
| July, 2026 | $12.68 | $6.3841 | $15.22 | +22.06% |
| August, 2026 | $11.15 | $6.27 | $13.38 | +7.31% |
| September, 2026 | $8.2565 | $2.7521 | $11.21 | -20.53% |
| October, 2026 | $13.51 | $8.4359 | $13.61 | +30.07% |
| November, 2026 | $7.0518 | $6.0818 | $13.53 | -32.13% |
| December, 2026 | $8.3188 | $5.8212 | $12.66 | -19.93% |
Adaptive Biotechnologies Corp Stock (ADPT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Adaptive Biotechnologies Corp (ADPT) is $6.1365, with a high forecast of $12.14 and a low forecast of $0.1341. This indicates an -40.94% decrease from the last price of $10.39.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.0665 | $0.1665 | $9.0782 | -89.74% |
| February, 2027 | $4.3641 | $0.1341 | $6.6647 | -58.00% |
| March, 2027 | $5.5088 | $1.3265 | $6.4782 | -46.98% |
| April, 2027 | $8.0912 | $7.1194 | $7.9712 | -22.13% |
| May, 2027 | $8.9435 | $8.2718 | $8.8334 | -13.92% |
| June, 2027 | $10.19 | $7.3453 | $8.0815 | -1.96% |
| July, 2027 | $12.17 | $11.78 | $12.14 | +17.12% |
| August, 2027 | $12.87 | $12.40 | $11.81 | +23.88% |
| September, 2027 | $10.64 | $10.93 | $11.83 | +2.45% |
| October, 2027 | $9.3065 | $9.7653 | $9.0515 | -10.43% |
| November, 2027 | $7.3888 | $7.2577 | $6.5588 | -28.89% |
| December, 2027 | $10.62 | $9.11 | $9.3118 | +2.23% |
Adaptive Biotechnologies Corp Stock (ADPT) Price Forecast for 2028
In 2028, Adaptive Biotechnologies Corp (ADPT) is projected to reach an average price of $5.5374, with a high projection of $9.5435 and a low estimate of $1.5312. This indicates an -46.70% fall from the last price of $10.39.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $10.05 | $10.03 | $9.5435 | -3.23% |
| February, 2028 | $6.5865 | $8.5459 | $8.6247 | -36.61% |
| March, 2028 | $6.9294 | $7.0988 | $7.2277 | -33.31% |
| April, 2028 | $6.2318 | $7.0818 | $7.0712 | -40.02% |
| May, 2028 | $3.9847 | $4.9747 | $4.6041 | -61.65% |
| June, 2028 | $4.6871 | $5.0671 | $4.5771 | -54.89% |
| July, 2028 | $4.2094 | $4.9744 | $4.1594 | -59.49% |
| August, 2028 | $4.7524 | $4.0306 | $3.54 | -54.26% |
| September, 2028 | $4.3847 | $5.1547 | $4.8541 | -57.80% |
| October, 2028 | $2.3071 | $3.4071 | $4.0303 | -77.80% |
| November, 2028 | $1.87 | $2.9144 | $3.4792 | -82.00% |
| December, 2028 | $3.0524 | $1.5312 | $2.5574 | -70.62% |
Adaptive Biotechnologies Corp Stock (ADPT) Price Forecast for 2029
The 2029 price forecast for Adaptive Biotechnologies Corp Stock (ADPT) is $25.57 on average, with a high prediction of $50.91 and a low estimate of $0.2183. This represents an +146.06% increase from the previous price of $10.39.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.6053 | $2.0297 | $2.648 | -74.92% |
| February, 2029 | $3.3077 | $2.4509 | $2.5677 | -68.16% |
| March, 2029 | $2.97 | $3.335 | $3.1088 | -71.41% |
| April, 2029 | $2.4424 | $2.7524 | $2.4518 | -76.49% |
| May, 2029 | $1.1153 | $1.3703 | $1.943 | -89.27% |
| June, 2029 | $1.3477 | $1.0659 | $0.9577 | -87.03% |
| July, 2029 | $1.09 | $1.3982 | $1.2344 | -89.51% |
| August, 2029 | $0.473 | $0.2824 | $0.495 | -95.45% |
| September, 2029 | $0.9453 | $0.7141 | $0.3397 | -90.90% |
| October, 2029 | $0.2827 | $0.2183 | $0.3471 | -97.28% |
| November, 2029 | $51.59 | $52.97 | $50.91 | +396.57% |
| December, 2029 | $47.35 | $51.67 | $49.62 | +355.71% |
Adaptive Biotechnologies Corp Stock (ADPT) Price Forecast for 2030
Adaptive Biotechnologies Corp Stock (ADPT) is expected to reach an average price of $43.42 in 2030, with a high forecast of $57.81 and a low forecast of $29.03. This signifies an +317.92% surge from the last price of $10.39.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $44.77 | $44.13 | $42.64 | +330.93% |
| February, 2030 | $54.81 | $48.61 | $55.06 | +427.56% |
| March, 2030 | $59.32 | $58.21 | $57.81 | +470.97% |
| April, 2030 | $55.19 | $56.49 | $55.92 | +431.17% |
| May, 2030 | $53.12 | $53.52 | $53.49 | +411.30% |
| June, 2030 | $52.90 | $52.91 | $52.06 | +409.16% |
| July, 2030 | $45.29 | $48.87 | $49.86 | +335.95% |
| August, 2030 | $56.15 | $52.27 | $53.47 | +440.42% |
| September, 2030 | $51.50 | $52.04 | $51.43 | +395.71% |
| October, 2030 | $39.74 | $45.35 | $47.98 | +282.48% |
| November, 2030 | $35.85 | $36.33 | $36.03 | +245.09% |
| December, 2030 | $25.11 | $29.03 | $29.85 | +141.67% |
0.59%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):